rs199538058
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2
The NM_000719.7(CACNA1C):c.5214C>A(p.Gly1738Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00133 in 1,613,558 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G1738G) has been classified as Benign.
Frequency
Consequence
NM_000719.7 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.5448C>A | p.Gly1816Gly | synonymous_variant | 44/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.5181C>A | p.Gly1727Gly | synonymous_variant | 41/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.5379C>A | p.Gly1793Gly | synonymous_variant | 43/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.5358C>A | p.Gly1786Gly | synonymous_variant | 44/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.5337C>A | p.Gly1779Gly | synonymous_variant | 42/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.5304C>A | p.Gly1768Gly | synonymous_variant | 42/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.5304C>A | p.Gly1768Gly | synonymous_variant | 42/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.5304C>A | p.Gly1768Gly | synonymous_variant | 42/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.5304C>A | p.Gly1768Gly | synonymous_variant | 42/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.5298C>A | p.Gly1766Gly | synonymous_variant | 43/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.5289C>A | p.Gly1763Gly | synonymous_variant | 43/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.5274C>A | p.Gly1758Gly | synonymous_variant | 43/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.5271C>A | p.Gly1757Gly | synonymous_variant | 42/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.5271C>A | p.Gly1757Gly | synonymous_variant | 42/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.5271C>A | p.Gly1757Gly | synonymous_variant | 42/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.5265C>A | p.Gly1755Gly | synonymous_variant | 42/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.5256C>A | p.Gly1752Gly | synonymous_variant | 42/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.5238C>A | p.Gly1746Gly | synonymous_variant | 41/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.5238C>A | p.Gly1746Gly | synonymous_variant | 41/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.5232C>A | p.Gly1744Gly | synonymous_variant | 41/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.5214C>A | p.Gly1738Gly | synonymous_variant | 42/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.5205C>A | p.Gly1735Gly | synonymous_variant | 42/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.5181C>A | p.Gly1727Gly | synonymous_variant | 41/46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.00114 AC: 173AN: 152232Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00127 AC: 313AN: 247232Hom.: 0 AF XY: 0.00132 AC XY: 178AN XY: 134350
GnomAD4 exome AF: 0.00134 AC: 1965AN: 1461208Hom.: 3 Cov.: 31 AF XY: 0.00139 AC XY: 1009AN XY: 726874
GnomAD4 genome AF: 0.00114 AC: 173AN: 152350Hom.: 1 Cov.: 33 AF XY: 0.00105 AC XY: 78AN XY: 74496
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 15, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | CACNA1C: BP4, BP7, BS1 - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 23, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 01, 2023 | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Long QT syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 27, 2015 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at